NCT03191669View on ClinicalTrials.gov

Vaccine Exposure in Patients With MS

CompletedOBSERVATIONAL
Enrollment

335

Participants

Timeline

Start Date

June 26, 2017

Primary Completion Date

July 7, 2017

Study Completion Date

July 7, 2017

Conditions
Multiple Sclerosis
Interventions
OTHER

Auto-questionnaire

Single Auto-questionnaire administered during or after a consultation/hospitalization

Trial Locations (6)

38043

Service de Neurologie - CHU de Grenoble, Grenoble

42055

Service de Neurologie - Hôpital Nord - CHU St Etienne, Saint-Etienne

63003

Service de Neurologie - Hôpital G. Montpied, Clermont-Ferrand

69007

Service de Neurologie - Hôpital Saint Joseph Saint Luc, Lyon

69009

Cabinet de Neurologie - Clinique de la Sauvegarde, Lyon

69500

Hôpital Neurologique Pierre Wertheimer, Bron

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03191669 - Vaccine Exposure in Patients With MS | Biotech Hunter | Biotech Hunter